TEVA · Teva Pharmaceutical Industries Ltd · Documents
Market Cap
$46.52B
Shares
1.17B
Volume · Oct 22
4.07M
Avg daily vol (3M)
5.68M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-04-18 | — | |
| ARS | — | 2024-04-16 | 2023-12-31 | |
| DEFA14A | — | 2024-04-16 | — | |
| DEF 14A | — | 2024-04-16 | 2024-06-06 | |
| 10-K | — | 2024-02-12 | 2023-12-31 | |
| 8-K | — | 2024-01-31 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-08 | — | |
| 8-K | — | 2023-10-04 | — | |
| 8-K | — | 2023-09-28 | 2023-09-25 | |
| 8-K | — | 2023-08-24 | 2023-08-21 | |
| 8-K | — | 2023-08-02 | — | |
| 10-Q | — | 2023-08-02 | 2023-06-30 | |
| 8-K | — | 2023-08-02 | 2023-08-01 | |
| 8-K | — | 2023-06-15 | — | |
| 8-K | — | 2023-06-08 | — | |
| DEFA14A | — | 2023-05-24 | — | |
| 8-K | — | 2023-05-11 | 2023-05-08 | |
| 8-K | — | 2023-05-10 | — | |
| 10-Q | — | 2023-05-10 | 2023-03-31 | |
| DEFA14A | — | 2023-04-19 | — | |
| ARS | — | 2023-04-19 | 2022-12-31 | |
| DEF 14A | — | 2023-04-19 | — | |
| 8-K | — | 2023-03-09 | — | |
| 8-K | — | 2023-03-03 | 2023-03-01 | |
| 10-K | — | 2023-02-10 | 2022-12-31 | |
| 8-K | — | 2023-02-08 | — | |
| 8-K | — | 2022-11-21 | 2022-11-18 | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-03 | — | |
| 10-Q | — | 2022-07-27 | 2022-06-30 | |
| 8-K | — | 2022-07-26 | — | |
| 8-K | — | 2022-06-23 | — | |
| 8-K | — | 2022-05-03 | — | |
| 10-Q | — | 2022-05-03 | 2022-03-31 | |
| DEFA14A | — | 2022-04-13 | — | |
| DEF 14A | — | 2022-04-13 | 2022-06-23 | |
| PRE 14A | — | 2022-03-15 | 2022-06-23 | |
| 8-K | — | 2022-02-24 | — | |
| 10-K | — | 2022-02-09 | 2021-12-31 | |
| 8-K | — | 2022-02-09 | — | |
| 8-K | — | 2021-11-24 | 2021-11-22 | |
| 8-K | — | 2021-11-10 | 2021-11-09 | |
| 8-K | — | 2021-11-04 | 2021-11-02 | |
| 8-K | — | 2021-11-02 | — | |
| 8-K | — | 2021-10-27 | 2021-09-30 | |
| 10-Q | — | 2021-10-27 | 2021-09-30 | |
| S-3ASR | — | 2021-10-27 | — | |
| 8-K | — | 2021-08-27 | 2021-08-26 | |
| 8-K | — | 2021-07-28 | 2021-06-30 |
Showing 51–100 of 127 filings
Key facts
CIK
818686
CUSIP
M8769Q102
13F (30d)
98 filings
86 filers
Visit website
Investor relations